$LQDA
Liquidia Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$66.43
▼-0.67%-$0.450
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateLiquidia Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is LQDA down today? It is at $66.43 (-0.67%), and our scanner flagged it 106 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LQDA spikes, and full due diligence on LQDA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LQDA 106 times in the last 30 days. Create a free account to track $LQDA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
LQDA is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on LQDA today, peaking at 9.9x its normal volume.
Likely catalystFDA Grants Fast Track Designation to YUTREPIA® for the TreatmentReported with systemic sclerosis-associated Raynaud's phenomenon (SSc-RP), a debilitating manifestation affecting up to 90% of SSc patientsReported in the fingers and toes. Affecting up to 90% of SSc patients, these attacks are more frequent, prolonged and severe than primary Raynaud's,Reported often progressing to digital ischemic ulcers in an estimated 40% to 60% of patients and, in recurrent cases, digital amputation. At a, from an SEC filing. Read it →Latest filing4Ownership documentSep 15, 2026 · 6 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Singh Raman Director | Sold (automatic/other) | -8K | sold 16% | 45K | $560K at $66.16 | Sep 14, 26 |
Singh Raman Director | Other | 8K | added 19% | 53K | $79K at $9.31 | Sep 14, 26 |
Singh Raman Director | Sold (automatic/other) | -9K 0.01% of company | sold 17% | 45K | $619K at $68.62 | Sep 11, 26 |
Singh Raman Director | Other | 9K 0.01% of company | added 20% | 54K | $78K at $8.63 | Sep 11, 26 |
Krepp Sarah Officer | Sold (automatic/other) | -274 | sold 0.2% | 117K | $19K at $67.76 | Sep 1, 26 |
Adair Jason Officer | Sold (automatic/other) | -74K 0.08% of company | sold 30% | 175K | $5.1M at $69.09 | Aug 21, 26 |
Adair Jason Officer | Other | 32K 0.04% of company | added 15% | 248K | $296K at $9.31 | Aug 21, 26 |
Rielly-Gauvin Katherine Director | Sold (automatic/other) | -18K 0.02% of company | sold 29% | 45K | $1.3M at $72.23 | Aug 20, 26 |
Rielly-Gauvin Katherine Director | Other | 18K 0.02% of company | added 41% | 63K | $46K at $2.51 | Aug 20, 26 |
Saggar Rajeev Officer | Sold (automatic/other) | -50K 0.06% of company | sold 26% | 142K | $3.7M at $74.06 | Aug 19, 26 |
Saggar Rajeev Officer | Other | 50K 0.06% of company | added 35% | 192K | $187K at $3.73 | Aug 19, 26 |
Rielly-Gauvin Katherine Director | Sold (automatic/other) | -37K 0.04% of company | sold 45% | 45K | $2.8M at $74.99 | Aug 19, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
LQDA is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on LQDA today, peaking at 9.9x its normal volume.
LQDA last traded at $66.43, down 0.67% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Liquidia Corporation Common Stock (LQDA) is next expected to report earnings on Monday, November 2, 2026, about 42 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The LQDA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LQDA 106 times in the last 30 days.
LQDA (Liquidia Corporation Common Stock) trades on XNAS, with a market cap of about $5.99B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LQDA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LQDA discussion
Sign in to ask a question or join the discussion.